Literature DB >> 34114

Some factors influencing the neurotoxicity of intrastriatal injections of kainic acid.

E G McGeer, P L McGeer.   

Abstract

Intrastriatal injections of kainic acid are known to destroy striatal neurons including many containing choline acetyltransferase (CAT) and glutamic acid decarboxylase (GAD). Using these enzymes as indices of neuronal loss, the neurotoxicity of small doses of kainic acid was found to be influenced by injection time and volume. It was partly blocked by coinjection of some but not all glutamate antagonists or by prior lesioning of the corticostriatal tract. Other adjuvants, drugs, or lesions tested had little modifying effect, except that changes in the dopaminergic system seemed to increase the toxicity towards cholinergic but not GABAnergic systems. High-affinity glutamate accumulation by neostriatal synaptosomes was significantly increased 1--7 days following kainic acid injections. MAO and acetylcholinesterase activities were depressed in kainic acid-lesioned striata but not nearly as much as were CAT and GAD. An indirect mechanism involving glutamate release and inhibition of reuptake is suggested for kainic acid neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 34114     DOI: 10.1007/bf00966331

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  24 in total

1.  Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids.

Authors:  E G McGeer; P L McGeer
Journal:  Nature       Date:  1976-10-07       Impact factor: 49.962

2.  A SENSITIVE AND SPECIFIC ASSAY FOR THE ESTIMATION OF MONOAMINE OXIDASE.

Authors:  R J WURTMAN; J AXELROD
Journal:  Biochem Pharmacol       Date:  1963-12       Impact factor: 5.858

3.  Glutamate neurotoxicity and Huntington's chorea.

Authors:  J W Olney; T de Gubareff
Journal:  Nature       Date:  1978-02-09       Impact factor: 49.962

4.  Structural requirements for the inhibition for L-glutamate uptake by glia and nerve endings.

Authors:  P J Roberts; J C Watkins
Journal:  Brain Res       Date:  1975-02-21       Impact factor: 3.252

5.  Inhibition of glutamate-elicited accumulation of adenosine cyclic 3',5'-monophosphate in brain slices by alpha, omega-diaminocarboxylic acids.

Authors:  H Shimizu; H Ichishita; I Umeda
Journal:  Mol Pharmacol       Date:  1975-11       Impact factor: 4.436

6.  A glutamatergic corticostriatal path?

Authors:  P L McGeer; E G McGeer; U Scherer; K Singh
Journal:  Brain Res       Date:  1977-06-10       Impact factor: 3.252

7.  The antagonistic action of glutamic acid diethylester towards amino acid-induced and synaptic excitations of central neurones.

Authors:  S Haldeman; H McLennan
Journal:  Brain Res       Date:  1972-10-27       Impact factor: 3.252

8.  Effect of some "strong" excitants of central neurones on the uptake of L-glutamate and L-aspartate by synaptosomes.

Authors:  J Lakshmanan; G Padmanaban
Journal:  Biochem Biophys Res Commun       Date:  1974-06-04       Impact factor: 3.575

9.  Effect of beta-N-oxalyl-L-alpha, beta-diaminopropionic acid on glutamate uptake by synaptosomes.

Authors:  J Lakshmanan; G Padmanaban
Journal:  Nature       Date:  1974-05-31       Impact factor: 49.962

10.  Cholinergic enzyme systems in Parkinson's disease.

Authors:  P L McGeer; E G McGeer
Journal:  Arch Neurol       Date:  1971-09
View more
  10 in total

1.  Increase in nucleoside diphosphatase in rat brain striatum lesioned with kainic acid.

Authors:  S Miyamoto; Y Matsuda; S Sano; H Shiraki; H Nakagawa
Journal:  Neurochem Res       Date:  1992-07       Impact factor: 3.996

Review 2.  Glutamate, GABA, and CNS disease: a review.

Authors:  J E Walker
Journal:  Neurochem Res       Date:  1983-04       Impact factor: 3.996

Review 3.  The current state of research with peripheral tissues in Huntington disease.

Authors:  G C Beverstock
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

4.  Acute effects of the neurotoxin kainic acid on neurons of the pigeon basal ganglia. Electrophysiological and light and electron microscopic observations.

Authors:  G K Rieke; D E Bowers
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

5.  Iontophoresis of kainic acid.

Authors:  J A McCaughran; E G McGeer
Journal:  Neurochem Res       Date:  1981-01       Impact factor: 3.996

Review 6.  Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy.

Authors:  A Fitton; K L Goa
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

7.  The toxin kainic acid: a study of avian nerve and glial cell response utilizing tritiated kainic acid and electron microscopic autoradiography.

Authors:  G K Rieke; H W Sampson; A D Scarfe; D E Bowers
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

8.  Kainic Acid-induced neurotoxicity: targeting glial responses and glia-derived cytokines.

Authors:  Xing-Mei Zhang; Jie Zhu
Journal:  Curr Neuropharmacol       Date:  2011-06       Impact factor: 7.363

9.  Melatonin Mediates Protective Effects against Kainic Acid-Induced Neuronal Death through Safeguarding ER Stress and Mitochondrial Disturbance.

Authors:  Feixiao Xue; Cai Shi; Qingjie Chen; Weijian Hang; Liangtao Xia; Yue Wu; Sophia Z Tao; Jie Zhou; Anbing Shi; Juan Chen
Journal:  Front Mol Neurosci       Date:  2017-02-28       Impact factor: 5.639

10.  Melatonin Mitigates Kainic Acid-Induced Neuronal Tau Hyperphosphorylation and Memory Deficits through Alleviating ER Stress.

Authors:  Cai Shi; Jia Zeng; Zixi Li; Qingjie Chen; Weijian Hang; Liangtao Xia; Yue Wu; Juan Chen; Anbing Shi
Journal:  Front Mol Neurosci       Date:  2018-01-24       Impact factor: 5.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.